Related by context. All words. (Click for frequent words.) 76 investigational antiplatelet agent 74 Cleviprex TM clevidipine 74 antiplatelet agent 71 phase IIb clinical 70 DAPT 69 sorafenib Nexavar 69 TBC# 69 PDE4 inhibitor 69 oral anticoagulant 69 visilizumab 69 eltrombopag 69 fondaparinux 69 pertuzumab 69 TELINTRA 69 goserelin 69 Mipomersen 69 CoFactor 68 AGILECT R 68 Phase Ib study 68 Torisel 68 Aflibercept 68 cediranib 68 oral rivaroxaban 68 Factor VIIa 68 PROMACTA 68 methylnaltrexone 68 octreotide 68 BAY #-# 68 Cloretazine 68 RSD# oral 68 DU #b 68 ancrod 68 mertansine 68 elotuzumab 68 Targretin 68 antiarrhythmic drug 68 posaconazole 68 oral ridaforolimus 68 CRMD# 68 rNAPc2 68 midstage clinical 67 Fibrillex TM 67 orBec 67 Androxal TM 67 ZOLINZA 67 bosutinib 67 INTEGRILIN 67 Reverset 67 tolevamer 67 eptifibatide 67 tecarfarin 67 pomalidomide 67 lomitapide 67 reslizumab 67 Dapagliflozin 67 Amrubicin 67 Lixivaptan 67 alvimopan 67 MYDICAR 67 Firazyr 67 Octreolin 67 xanthine oxidase inhibitor 67 oral prodrug 67 decitabine 67 rivaroxaban 67 axitinib 67 Personalized Immunotherapy 67 Ambrisentan 67 forodesine 67 MAGE A3 ASCI 67 idraparinux 67 subcutaneously administered 67 sargramostim 66 Corlux 66 CCR5 antagonist 66 Phase IIb clinical trials 66 Pimavanserin 66 VAPRISOL 66 YONDELIS 66 active comparator 66 tolvaptan 66 dirucotide 66 Dasatinib 66 Fibrin Pad 66 Dyloject TM 66 SinuNase 66 vorinostat 66 Xinlay 66 PRT# 66 temsirolimus 66 platelet inhibitor 66 thalidomide Thalomid 66 figitumumab 66 Vernakalant 66 daclizumab 66 budesonide foam 66 rFVIIa 66 vicriviroc 66 clopidogrel Plavix 66 rhThrombin 66 VA# [002] 66 direct thrombin inhibitors 66 JAK inhibitor 66 Nuvion 66 febuxostat 66 Plicera 66 sitaxsentan 66 NATRECOR R 66 OHR/AVR# 66 EOquin 66 iniparib 66 Tolvaptan 66 herpetic keratitis 66 lapatinib Tykerb 66 ACTEMRA TM 66 SinuNase TM 66 Bicifadine 66 Fludara 66 ELND# 66 Bezielle 66 Aptivus ® 66 palonosetron 66 teriflunomide 66 RSD# 66 Vaprisol 66 Rivaroxaban 66 NV1FGF 66 ULORIC 66 Noxafil 66 vandetanib 66 antithrombotic 65 APTIVUS 65 vinorelbine 65 Laquinimod 65 GAMMAGARD 65 mycophenolate mofetil 65 NEVO ™ 65 Phase Ib clinical 65 romiplostim 65 clazosentan 65 Nebido 65 Xanafide 65 etravirine 65 Panzem R NCD 65 Candesartan 65 OMS# 65 Capesaris 65 adipiplon 65 Tarceva TM 65 Archexin 65 relapsed multiple myeloma 65 regorafenib 65 HQK 65 inhibitor RG# 65 TLK# 65 Factor Xa inhibitor 65 opioid induced bowel dysfunction 65 riociguat 65 nalbuphine ER 65 alpha blocker 65 Velcade bortezomib 65 octreotide acetate 65 oxaliplatin Eloxatin 65 Troxatyl 65 aspirin clopidogrel 65 phase IIb trial 65 bazedoxifene 65 bendamustine 65 corticosteroid dexamethasone 65 Dabigatran etexilate 65 alkylating agent 65 Darusentan 65 aflibercept 65 PNP inhibitor 65 cilostazol 65 Proxinium TM 65 Factor IX 65 Ozarelix 65 EFAPROXYN 65 refractory gout 65 beta 1a 65 tiapamil 65 eprotirome 65 XmAb# 65 acyclovir Lauriad R 65 Clonicel 65 ABSORB trial 65 albiglutide 65 elinogrel 65 tocilizumab 65 targeted radiotherapeutic 65 Degarelix 65 dexanabinol 65 GVAX 65 Telintra 65 MGd 65 T Pred 65 vinca alkaloid 65 mTOR inhibitor 65 PRADAXA 65 vemurafenib 65 Allovectin 7 65 receptor tyrosine kinase inhibitor 65 Clolar ® 65 AZILECT R 65 QTc prolongation 65 dalbavancin 65 FTY# 65 Zybrestat 65 immunomodulatory therapy 65 STRIDE PD 65 OncoVEX GM CSF 65 amphotericin B 65 neratinib 65 Phenoptin 65 CD3 monoclonal antibody 65 TKM ApoB 65 Phase 2b study 65 candesartan cilexetil 65 Natalizumab 65 Fludara ® 65 clevidipine 65 postoperative ileus 65 alvespimycin 65 elacytarabine 65 eplerenone 65 ORENCIA R 65 thromboembolic events 65 alogliptin 65 tasocitinib 65 systemic immunosuppressive drugs 65 olmesartan 65 Ereska 65 REG1 65 pharmacokinetic equivalence 65 tramiprosate 65 Aurexis 65 phase IIb 65 gefitinib Iressa 65 VELCADE melphalan 65 SILENOR 65 Temsirolimus 65 ocrelizumab 65 Silodosin 64 BRINAVESS 64 Phase #b/#a trial 64 PRISTIQ 64 abiraterone acetate 64 ZACTIMA 64 nucleoside analog 64 Dabigatran 64 lanreotide 64 sunitinib malate 64 HGS# 64 CA4P 64 faropenem 64 Lenalidomide 64 standard chemotherapy regimen 64 novel oral anticoagulant 64 tiotropium 64 treprostinil 64 OncoGel 64 muraglitazar 64 intranasal formulation 64 LCP Tacro 64 iclaprim 64 IIIa inhibitor 64 oral talactoferrin 64 IMA# 64 Omigard 64 IRX 2 64 ritonavir boosted 64 Triapine R 64 belinostat 64 Zerenex 64 inhaled formulation 64 Entereg 64 budiodarone 64 Cangrelor 64 Traficet EN 64 erlotinib Tarceva ® 64 enzastaurin 64 Alfimeprase 64 vernakalant 64 EOquin TM 64 OvaRex ® MAb 64 CANCIDAS 64 TNF Tumor Necrosis Factor 64 thrombolytics 64 Navelbine ® 64 LY# [003] 64 prasugrel Effient 64 pegylated interferons 64 pegylated liposomal doxorubicin 64 PEGINTRON TM 64 TELCYTA 64 oral methylnaltrexone 64 Ixempra 64 MIRCERA 64 factor Xa 64 PDX pralatrexate 64 Acapodene 64 octreotide implant 64 phase IIa clinical 64 Ketotransdel 64 efficacy endpoint 64 Tyrima 64 rifalazil 64 Vilazodone 64 SEPET TM 64 anidulafungin 64 angiogenesis inhibitor 64 RAPAFLO 64 selective modulator 64 selective androgen receptor modulator 64 postoperative ileus POI 64 ATACAND 64 Carvedilol 64 Abbokinase 64 Voraxaze 64 Glypromate 64 pan HDAC inhibitor 64 generation purine nucleoside 64 desvenlafaxine succinate 64 Combo Stent 64 SERMs 64 TAXUS Express Stent 64 trastuzumab Herceptin 64 edifoligide 64 ADAGIO study 64 TRO# 64 docetaxel chemotherapy 64 severe hypercholesterolemia 64 bivalirudin 64 Onconase 64 fenretinide 64 Pafuramidine 64 anticancer compound 64 terlipressin 64 unfractionated heparin 64 Kepivance 64 ximelagatran 64 INCB# [001] 64 ONTAK 64 GP IIb IIIa inhibitors 64 DPP4 inhibitor 64 Herceptin trastuzumab 64 ixabepilone 64 daptomycin 64 irbesartan 64 Viramidine 64 efalizumab 64 HuMax EGFr 64 granisetron 64 ocular formulation 64 ranolazine 64 BENICAR HCT 64 dextofisopam 64 PRIMO CABG 64 obatoclax 64 oxymorphone ER 64 midstage studies 64 Certolizumab pegol 64 proteasome inhibitor 64 Phase Ib II 64 trastuzumab DM1 T DM1 64 angiotensin receptor blocker ARB 64 AGGRASTAT R 64 PrevOnco ™ 64 Dronedarone 64 metastatic hormone refractory 64 Tezampanel 64 TREDAPTIVE 64 Nexavar sorafenib 64 pain palliation 64 Pemetrexed 64 adecatumumab 64 intravenous cyclophosphamide 64 solanezumab 64 CIMZIA ™ 64 oxypurinol 64 Exemestane 64 AGGRASTAT ® 64 Resten NG 64 metaglidasen 64 Relovair 64 motesanib 64 CBLC# 64 Gefitinib 64 pioglitazone HCl 64 azacitidine 64 tamsulosin 64 direct thrombin inhibitor 64 Teriflunomide 64 Panzem R 64 ribavirin RBV 64 INT# [002] 64 Proellex TM 64 TYGACIL 64 ticagrelor 64 Promacta 64 Ophena TM 64 FOLOTYN ® 64 IV Busulfex 64 paricalcitol 64 AEG# 64 ARCOXIA 64 AEGR 64 NATRECOR ® 64 tafamidis 64 SNRI 64 NVA# 64 Neurodex 64 Civacir 64 carvedilol 64 TAXUS Element Stent System 64 CIMZIA TM certolizumab pegol 64 Dalbavancin 64 Doxil ® 64 Tasimelteon 64 Relivar 64 concurrent chemoradiation 64 ezetimibe simvastatin 64 Abiraterone 64 Onbrez Breezhaler 64 fulvestrant 64 Cethromycin 64 liposomal formulation 64 erlotinib Tarceva 64 Fodosine 64 HMG CoA reductase inhibitors 64 azilsartan medoxomil 64 orally administered inhibitor 64 LAF# 64 Viprinex 64 FROVA 64 Bicalutamide 64 registrational trial 64 BRIM2 64 IV NSCLC 64 Afresa 64 somatostatin analogue 64 TNF inhibitor 63 Femara letrozole 63 baminercept 63 CTAP# Capsules 63 adalimumab Humira 63 GP IIb IIIa inhibitor 63 calcineurin inhibitor 63 6R BH4 63 olaparib 63 CHAMPION PCI 63 Dacogen injection 63 plasma kallikrein inhibitor 63 SPIRIVA ® 63 tesmilifene 63 recurrent glioblastoma 63 pradefovir 63 Pruvel 63 tenofovir emtricitabine 63 fluvastatin 63 Eraxis 63 Catena ® 63 canakinumab 63 MYDICAR ® 63 abacavir lamivudine 63 amrubicin 63 Ocrelizumab 63 ATL# [001] 63 levosimendan 63 edoxaban 63 galantamine 63 betrixaban 63 sorafenib tablets 63 darapladib 63 Phase IIa trials 63 VPRIV 63 uric acid lowering 63 lasofoxifene 63 Ticagrelor 63 integrase inhibitor 63 diarrhea predominant irritable 63 calcineurin inhibitors 63 ruxolitinib 63 vidofludimus 63 MKC# MKC# PP 63 IL# PE#QQR 63 zotarolimus eluting stent 63 PEG IFN 63 Lubiprostone 63 apremilast 63 Vandetanib 63 Arixtra 63 MEK inhibitors 63 biologic DMARD 63 PrevOnco 63 histone deacetylase HDAC inhibitor 63 latanoprost 63 QuadraSphere 63 OZURDEX ® 63 abiraterone 63 ELACYT 63 zalutumumab 63 CytoFabTM 63 Arcalyst 63 phase IIa 63 RhuDex ® 63 bardoxolone methyl 63 Chemophase 63 bevacizumab Avastin ® 63 metastatic HRPC 63 mRCC 63 composite endpoint 63 Zolinza 63 selegiline 63 orally inhaled 63 Leukine ® 63 noninferiority 63 RE LY 63 cinacalcet HCl 63 interferon beta therapy 63 antiplatelet therapy 63 tipranavir 63 oral beclomethasone dipropionate 63 5-FU/LV 63 cortical stimulation 63 fenofibric acid 63 INCB# [003] 63 budesonide 63 anti androgen 63 adefovir 63 boosted protease inhibitor 63 clodronate 63 Phase IIb trials 63 Myocet 63 LEUKINE 63 liposomal amphotericin B 63 Itopride 63 sapacitabine 63 doripenem 63 MyVax 63 rolofylline 63 talactoferrin 63 Avanafil 63 APEX PD 63 lumiliximab 63 SCH # 63 GOUT 63 teriparatide 63 ponatinib 63 zafirlukast 63 verteporfin 63 cathepsin K inhibitor 63 efaproxiral 63 RLY# 63 fosbretabulin 63 AVASTIN 63 LEP ETU 63 subcutaneous formulation 63 Squalamine 63 trospium 63 thymalfasin 63 Aplidin 63 Omnitarg 63 protease inhibitor PI 63 Interferon alpha 63 Mylotarg 63 galiximab 63 INTEGRILIN ® 63 Elvitegravir 63 argatroban 63 Irinotecan 63 Virulizin ® 63 Elitek 63 treat chronic sinusitis 63 Cancidas 63 velafermin 63 LMWH 63 Actemra tocilizumab 63 Ventavis 63 Bronchitol 63 MEND CABG II 63 Tekamlo 63 LibiGel ® 63 naproxen esomeprazole magnesium 63 CIMZIA TM 63 vascular disrupting agent 63 OvaRex 63 Cytoxan 63 Azedra TM 63 Myelodysplastic Syndrome MDS 63 GLP toxicology studies 63 telcagepant 63 Dextofisopam 63 EP #R 63 atrasentan 63 lintuzumab 63 milrinone 63 potent CYP#A# inhibitors 63 nitazoxanide 63 Frova ® 63 Atacand 63 nilotinib 63 glufosfamide 63 dosage regimens 63 confirmatory clinical 63 glatiramer acetate 63 icatibant 63 Cloretazine ® 63 salmeterol fluticasone 63 pegfilgrastim 63 Vidaza azacitidine 63 Daclizumab 63 valsartan 63 BeneFIX 63 Zenvia ™ 63 heparins 63 Evicel 63 serum phosphorous 63 metastatic castration resistant 63 gemcitabine Gemzar 63 rALLy clinical trial 63 HCV protease inhibitor 63 Telavancin 63 Fibrillex 63 Apixaban 63 darunavir 63 rituximab Rituxan 63 Dacogen decitabine 63 aripiprazole Abilify 63 sipuleucel T 63 Zingo TM 63 Phase IIa trial 63 Phase IIB 63 CDP# 63 glycoprotein IIb IIIa inhibitor 63 Pralatrexate 63 aldosterone antagonists 63 SNT MC# 63 caspofungin 63 Alocrest 63 liprotamase 63 TYSABRI natalizumab 63 factor Xa inhibitor 63 hyaluronidase enzyme 63 DEB# 63 streptokinase 63 tremelimumab 63 docetaxel Taxotere ® 63 nicardipine 63 Radezolid 63 midstage clinical trials 63 BEMA TM Fentanyl 63 Desmoteplase 63 Revlimid lenalidomide 63 Jevtana 63 Aclidinium 63 arterial thrombosis 63 Targretin capsules 63 lurasidone 63 GALNS 63 OMNARIS HFA 63 ORENCIA ® 63 degarelix 63 systemically administered 63 oral anticoagulants 63 NP2 Enkephalin 63 GSK# [001] 63 tanespimycin 63 ALGRX 63 CCR5 inhibitor 63 immunomodulator 63 Starlix 63 Cimzia TM 63 huC# DM4 63 Sirolimus eluting Coronary Stent 63 reteplase 63 selective estrogen receptor modulator 63 echinocandin 63 gatifloxacin 62 Bortezomib 62 pegloticase 62 cetuximab Erbitux R 62 APTIVUS R 62 Phase 2a trial 62 OSMOPREP 62 cancer immunotherapies 62 elagolix 62 idarubicin 62 darusentan 62 orally bioavailable 62 Focalin XR 62 TriRima 62 dasatinib Sprycel 62 trabectedin 62 pamidronate 62 MICARDIS ® 62 AZILECT ® 62 tezampanel 62 paclitaxel Taxol 62 BRAF inhibitor 62 Edoxaban 62 dasatinib 62 nucleotide analogue 62 FOLFOX4 62 Entereg R 62 severe gastroparesis 62 Perforomist ™ Inhalation Solution 62 catheter occlusion 62 PTH analogue 62 picoplatin 62 superficial bladder cancer 62 Atrasentan 62 dalteparin 62 tirofiban 62 BAL# [002] 62 bevacizumab Avastin 62 Zalbin 62 IFN beta 62 Phase IIIb clinical 62 MNTX 62 tezampanel NGX# 62 VIRAMUNE 62 UPLYSO 62 PEGylated interferon beta 1a 62 PSMA ADC 62 ProSavin 62 investigational pharmacologically unique 62 somatostatin analog 62 aleglitazar 62 ularitide 62 lesinurad 62 palifosfamide 62 raltegravir 62 nadolol 62 CINTREDEKIN BESUDOTOX 62 dacarbazine 62 R#/MEM # 62 romidepsin 62 Vectibix panitumumab 62 Urocortin 2 62 Enzyme Replacement Therapy 62 TORISEL 62 Vimpat R 62 CYC# 62 MIST II 62 Peg IFN 62 cilengitide 62 Trofex 62 Ecallantide 62 forodesine hydrochloride 62 everolimus eluting stents 62 thrombolytic agents 62 Nexavar ® 62 Iluvien ® 62 ritonavir boosted lopinavir 62 multicenter Phase II 62 Moxifloxacin 62 Ophena 62 PEG SN# 62 SPIRIVA HandiHaler 62 elvitegravir 62 tarenflurbil 62 Perforomist Inhalation Solution 62 Tacrolimus 62 cetuximab Erbitux ® 62 CYT# potent vascular disrupting 62 Lung Rx 62 torezolid phosphate 62 LY# [002] 62 EDEMA3 trial 62 Toremifene 62 adenosine injection 62 metastatic malignant 62 relapsed refractory multiple myeloma 62 ganciclovir 62 HuLuc# 62 drug eluting stent DES 62 palifermin 62 TYZEKA 62 MabThera rituximab 62 OvaRex R 62 Rasagiline 62 GSK# [002] 62 SUPPRELIN R LA 62 TOCOSOL Paclitaxel 62 Pivotal Phase III 62 Asentar 62 confirmatory Phase III 62 PDE4 inhibitors 62 nab paclitaxel 62 Zoraxel 62 sunitinib Sutent 62 trastuzumab DM1 62 infliximab Remicade 62 Multaq R 62 alfimeprase 62 FIRMAGON R 62 gamma secretase inhibitor 62 Specifid 62 pharmacodynamic properties 62 adalimumab 62 abciximab 62 dronedarone 62 apricitabine 62 MAP# 62 QTinno TM 62 SinuNase ™ 62 peginterferon alfa 2b 62 EDEMA3 62 BENICAR 62 Elocalcitol 62 Microplasmin 62 Insegia 62 interferon ribavirin 62 BYSTOLIC 62 castrate resistant prostate cancer 62 mapatumumab 62 interferon alfa 2b 62 Vfend 62 immunosuppressant drug 62 antiplatelet 62 Advagraf 62 cancer neuroendocrine tumor 62 plus prednisone 62 PXD# 62 surrogate endpoint 62 Alzhemed TM 62 pexelizumab 62 Prograf ® 62 thrombolytic agent 62 pharmacokinetic PK study 62 dexamethasone Decadron 62 deforolimus 62 Sprycel dasatinib 62 Mycamine 62 cannabinor 62 antiarrhythmic drugs 62 oral antiplatelet 62 methylnaltrexone bromide 62 GRN# 62 Hydroxyurea 62 Vicinium TM 62 HCV RESPOND 2 62 revascularization procedures 62 Tesetaxel 62 ambrisentan 62 phase Ib 62 enoximone capsules 62 angiotensin II receptor blocker 62 Aliskiren 62 SPRYCEL ® 62 interferon beta 1b 62 small molecule tyrosine 62 custirsen 62 Ranolazine 62 vascular disrupting agents 62 Androxal 62 aprepitant 62 incyclinide 62 Empatic 62 Orally administered 62 ACZ# 62 midstage trials 62 Telatinib 62 levodopa carbidopa 62 relapsed MM 62 ARIXTRA 62 Androxal ® 62 agomelatine 62 Tocosol Paclitaxel 62 Ceflatonin 62 urocortin 2 62 intravenous methylnaltrexone 62 Aggrastat 62 ganetespib 62 RezularTM 62 Prosaptide 62 antiarrhythmic 62 GTC recombinant human 62 lenalidomide Revlimid R 62 gadobutrol 62 Veronate 62 FOLFIRI 62 TNF antagonist 62 acute decompensated heart 62 paliperidone ER 62 brivaracetam 62 cabazitaxel 62 Abciximab 62 including eniluracil ADH 62 paclitaxel eluting stent 62 AGILECT ® 62 oxcarbazepine 62 docetaxel Taxotere 62 CAPHOSOL 62 radiation sensitizer 62 Insulin PH# 62 vernakalant hydrochloride 62 paliperidone palmitate 62 Cinquil 62 abatacept Orencia 62 Amplimexon 62 INKP 62 mTOR inhibitors 62 ATL/TV# 62 SUTENT 62 ADP receptor antagonist 62 XIENCE V stent 62 novel histone deacetylase 62 Mitoxantrone 62 Synavive 62 Taxol paclitaxel 62 Elacytarabine 62 Hycamtin ® 62 AZD# 62 Afatinib 62 rFIXFc 62 HuMax CD4 62 intravenous iv 62 divalproex sodium 62 Prestara 62 natalizumab 62 teduglutide 62 pegylated interferon alfa 62 weekly subcutaneous injections 62 GnRH antagonist 62 senicapoc 62 PEGylated Fab fragment 62 Epirubicin 62 ENMD # 62 Sym# 62 Naproxcinod 62 Cloretazine R VNP#M 62 Saxagliptin 62 IPLEX 62 Tracleer R 62 metformin HCl 62 recurrent glioblastoma multiforme 62 BrachySil TM 62 rHuPH# 62 R sorafenib tablets 62 PEG uricase 62 bucindolol 62 Carfilzomib 62 Valsartan 62 pazopanib 62 bortezomib Velcade 62 cytotoxic therapy 62 inhaled liposomal ciprofloxacin 62 Octreotide 62 Eltrombopag 62 QVA# 62 antihypertensive agents 62 GW# [003] 62 long acting muscarinic 62 ruboxistaurin 62 fostamatinib 62 PANVAC VF 62 zileuton IV 62 bezafibrate 62 sJIA 62 polymerase inhibitor 62 Xyotax 62 FASLODEX 62 Zavesca R 62 JAK1 62 Sandostatin LAR 62 Hyphanox 62 trastuzumab Herceptin ® 62 donepezil Aricept 62 Mepact 62 BCR ABL inhibitor 62 cell lymphoma CTCL 62 RoACTEMRA 62 Xelox 62 NOXAFIL 62 MIRAPEX ER 62 #I TM# 62 PREOS 62 Certolizumab 62 Technosphere Insulin 62 Abacavir 62 Riquent 62 Keppra XR 62 integrin inhibitor 62 ThGRF 62 abatacept 62 Anturol TM 62 Fx #A 62 abacavir Ziagen 62 phase IIIb 62 virologic failure 62 intravenously administered 62 Oral NKTR 62 Puricase 62 Drug Eluting Stent System 62 Rotigotine 62 LHRH agonists